Every filing for G23549101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Qiming Managing Directors Fund V, L.P.
13G/A
Amendment 2
|
2.9% |
11/3/2026
Event 9/30/2026
|
|
| Qiming Managing Directors Fund V, L.P. | 0.1% | ||
| Qiming Venture Partners V, L.P. | 2.8% | ||
| Qiming Corporate GP V, Ltd. | 2.9% | ||
| Qiming GP V, L.P. | 2.8% | ||
| Qiming GP VII, LLC | 1.5% | ||
| Qiming Venture Partners VII, L.P. | 1.5% | ||
| Qiming VII Strategic Investors Fund, L.P. | 0% | ||
|
BML Investment Partners, L.P.
13G
|
6.8% |
10/6/2026
Event 9/30/2026
|
|
| BML Investment Partners, L.P. | 6.1% | ||
| Braden M Leonard | 6.8% | ||
|
Panacea Innovation Ltd
13D/A
Amendment 5
|
21.2% |
4/1/2026
Event 3/31/2026
|
|
| Panacea Innovation Limited | 21.2% | ||
| Panacea Venture Healthcare Fund II, L.P. | 21.2% | ||
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 21.2% | ||
| James Huang | 21.2% | ||
|
Panacea Innovation Ltd
13D/A
Amendment 4
|
21.5% |
11/26/2025
Event 11/24/2025
|
|
| Panacea Innovation Limited | 21.5% | ||
| Panacea Venture Healthcare Fund II, L.P. | 21.5% | ||
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 21.5% | ||
| James Huang | 21.5% |